Invivyd Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.95

+0.02 (+2.08%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,151.6% upside

Low Target $15.01

Average Target $21.48

High Target $34.49

Current Price $0.95

Current
$0.95

Target
$21.48

$15.01 $21.48 avg $34.49

Scenario Analysis

Bear Case

$15.01

1,473.4%

Low target

Base Case

$21.48

+2,151.6%

Avg target

Bull Case

$34.49

+3,515.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.07

-68.9% from high

52-Week Low

$0.48

+97.5% from low

Target vs 52W High

$21.48

+599.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%